New Opportunities in Chemoprevention Research

REFERENCES

• Bailar J.C., III, Gornik H.L. Cancer Undefeated. N. Engl. J. Med. 1997; 336(22)1569–1574
   PubMed Web of Science ®Google Scholar
• Greenlee R.T., Murray T., Bolden S., Wingo P.A. Cancer Statistics, 2000. Cancer J. Clin. (CA) 2000; 50: 7–33
   PubMed Web of Science ®Google Scholar
• Doll R., Peto R. The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today. J. Natl. Cancer Inst. 1981; 66(6)1191–1308
   PubMed Web of Science ®Google Scholar
• Fisher B., Costantino J.P., Wickerham D.L., Redmond C.K., Kavanah M., Cronin W.M., Vogel V., Robidoux A., Dimitrov N., Atkins J., Daly M., Wieand S., Tan-Chiu E., Ford L., Wolmark N. Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst. 1998; 90(18)1371–1388
   PubMed Web of Science ®Google Scholar
• Albanes D., Heinonen O.P., Taylor P.R., Virtamo J., Edwards B.K., Rautalahti M., Hartman A.M., Palmgren J., Freedman L.S., Haapakoski J., Barrett M.J., Pietinen P., Malila N., Tala E., Liippo K., Salomaa E.R., Tangrea J.A., Teppo L., Askin F.B., Taskinen E., Erozan Y., Greenwald P., Huttunen J.K. Alpha-Tocopherol and Beta-Carotene Supplements and Lung Cancer Incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: Effects of Base-Line Characteristics and Study Compliance. J. Natl. Cancer Inst. 1996; 88: 1560–1570
   PubMed Web of Science ®Google Scholar
• Clark L.C., Combs G.F., Jr., Turnbull B.W., Slate E.H., Chalker D.K., Chow J., Davis L.S., Glover R.A., Graham G.F., Gross E.G., Krongrad A., Lesher J.L., Jr., Park H.K., Sanders B.B., Jr., Smith C.L., Taylor J.R. Effects of Selenium Supplementation for Cancer Prevention in Patients with Carcinoma of the Skin. A Randomized Controlled Trial. Nutritional Prevention of Cancer Study Group. J. Am. Med. Assoc. 1996; 276: 1957–1963
   PubMed Web of Science ®Google Scholar
• Wang T.T., Sathyamoorthy N., Phang J.M. Molecular Effects of Genistein on Estrogen Receptor Mediated Pathways. Carcinogenesis 1996; 17: 271–275
   PubMed Web of Science ®Google Scholar
• Cassidy A., Bingham S., Setchell K.D. Biological Effects of a Diet of Soy Protein Rich in Isoflavones on the Menstrual Cycle of Premenopausal Women. Am. J. Clin. Nutr. 1994; 60: 333–340
   PubMed Web of Science ®Google Scholar
• Schwartz J.A., Liu G., Brooks S.C. Genistein-mediated Attenuation of Tamoxifen-Induced Antagonism from Estrogen Receptor-Regulated Genes. Biochem. Biophys. Res. Commun. 1998; 253: 38–43
   PubMed Web of Science ®Google Scholar
• Shen F., Xue X., Weber G. Tamoxifen and Genistein Synergistically Down-Regulate Signal Transduction and Proliferation in Estrogen Receptor-Negative Human Breast Carcinoma MDA-MB-435 Cells. Anticancer Res. 1999; 19: 1657–1662
   PubMed Web of Science ®Google Scholar
• Nemoto T., Tominaga T., Chamberlain A., Iwasa Z., Koyama H., Hama M., Bross I., Dao T. Differences in Breast Cancer Between Japan and the United States. J. Natl. Cancer Inst. 1977; 58: 193–197
   PubMed Web of Science ®Google Scholar
• Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., Keogh J.P., Meyskens F.L., Jr., Valanis B., Williams J.H., Jr., Barnhart S., Cherniack M.G., Brodkin C.A., Hammar S. Risk Factors for Lung Cancer and for Intervention Effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J. Natl. Cancer Inst. 1996; 88: 1550–1559
   PubMed Web of Science ®Google Scholar
• Palozza P., Luberto C., Calviello G., Ricci P., Bartoli G.M. Antioxidant and Pro-oxidant Role of Beta-Carotene in Murine Normal and Tumor Thymocytes: Effects of Oxygen Partial Pressure. Free Radic. Biol. Med. 1997; 22: 1065–1073
   PubMed Web of Science ®Google Scholar
• Wang X.D., Liu C., Bronson R.T., Smith D.E., Krinsky N.I., Russell M. Retinoid Signaling and Activator Protein-1 Expression in Ferrets Given Beta-Carotene Supplements and Exposed to Tobacco Smoke. J. Natl. Cancer Inst. 1999; 91: 60–66
   PubMed Web of Science ®Google Scholar
• Hussain, M.; Sarkar, F.; Djuric, Z.; Pollak, M.; Banerjee, M.; Fontana, J.; Eilender, D.; Davis, J.; Chinni, S.; Trivedi, C.; Forman, J.; Wood, D.; Kucuk, O. Soy Isoflavones Modulate Serum PSA Level in Patients with Prostate Cancer, submitted for publication.
   Google Scholar
• Hirschi K.K., Xu C.E., Tsukamoto T., Sager R. Gap Junction Genes Cx26 and Cx43 Individually Suppress the Cancer Phenotype of Human Mammary Carcinoma Cells and Restore Differentiation Potential. Cell Growth Differ. 1996; 7(7)861–870
   PubMedGoogle Scholar
• Zhang L.X., Cooney R.V., Bertram J.S. Carotenoids Up-Regulate Connexin43 Gene Expression Independent of Their Provitamin A or Antioxidant Properties. Cancer Res. 1992; 52(20)5707–5712
   PubMed Web of Science ®Google Scholar
• Machlin L.J., Bendich A. Free Radical Tissue Damage; Protective Role of Antioxidant Micronutrients. FASEB J. 1987; 1: 441–445
   PubMed Web of Science ®Google Scholar
• Roy R.M., Petrella M., Shateri H. Effect of Administering Tocopherol After Irradiation on Survival and Proliferation of Murine Lymphocytes. Pharmacol. Ther. 1988; 39: 393–395
   PubMed Web of Science ®Google Scholar
• Tengerdy R.P., Mathias M.M., Nockels C.F. Vitamin E, Immunity and Disease Resistance. Adv. Exp. Med. Biol. 1981; 135: 27–42
   PubMed Web of Science ®Google Scholar
• Lopez I., Goudou C., Ribrag V., Sauvage C., Hazebroucq G., Dreyfus F. Treatment of Mucositis with Vitamin E During Administration of Neutropenic Antineoplastic Agents. Ann. Med. Intern. (Paris) 1994; 145: 405–408
   PubMedGoogle Scholar
• Wadleigh R., Redman R., Cohen M., Krasnow S., Anderson A., Graham M. Vitamin E in the Treatment of Chemotherapy-Induced Mucositis. Proc. Am. Soc. Clin. Oncol. 1990; 9: A1237
   Google Scholar
• Myers C., McGuire W., Young R. Adriamycin Amelioration of Toxicity by Alpha-Tocopherol. Cancer. Treat. Rep. 1976; 60: 961–962
   PubMedGoogle Scholar
• Srinivasan V., Weiss J.F. Radioprotection by Vitamin E: Injectable Vitamin E Administered Alone or with WR-3689 Enhances Survival of Irradiated Mice. Int. J. Radiat. Oncol. Biol. Phys. 1992; 23: 841–845
   PubMed Web of Science ®Google Scholar
• Mills E.E. The Modifying Effect of Beta-Carotene on Radiation and Chemotherapy Induced Oral Mucositis. Br. J. Cancer 1988; 57: 416–417
   PubMed Web of Science ®Google Scholar
• Klimberg V.S., Souba W.W., Dolson D.J., Salloum R.M., Hautamaki R.D., Plumley D.A., Mendenhall W.M., Bova F.J., Khan S.R., Hackett R.L., Bland K.I., Copeland E.M., III. Prophylactic Glutamine Protects the Intestinal Mucosa from Radiation Injury. Cancer 1990; 66: 62–68
   PubMed Web of Science ®Google Scholar
• Carroll M.P., Zera R.T., Roberts J.C., Schlafmann S.E., Feeney D.A., Johnston D.R., West M.A., Bubrick M.P. Efficacy of Radioprotective Agents in Preventing Small and Large Bowel Radiation Injury. Dis. Colon Rectum 1995; 38: 716–722
   PubMed Web of Science ®Google Scholar
• Meyer K.B., Madias N.E. Cisplatin Nephrotoxicity. Miner. Electrolyte Metab. 1994; 20: 201–213
   PubMedGoogle Scholar
• Baldew G.S., Van den Hamer C.J.A., Los G., Vermeulen N.P.E., De Goeij J.J.M., McVie J.G. Selenium-Induced Protection Against Cis-Diamminedichloroplatinum(II) Nephrotoxicity in Mice and Rats. Cancer Res. 1989; 49: 3020–3023
   PubMed Web of Science ®Google Scholar
• El-Bayoumy K. The Role of Selenium in Cancer Prevention. Practice of Oncology, V.T. DeVita, S. Hellman, K. Rosenberg. 4th Ed., J.B. Lippincott, Philadelphia, PA 1991; 1–15
   Google Scholar
• Sadzuka Y., Shoji T., Takino Y. Mechanism of the Increase in Lipid Peroxide Induced by Cisplatin in the Kidneys of Rats. Toxicol. Lett. 1992; 62: 293–300
   PubMed Web of Science ®Google Scholar
• Sugihara K., Nakano S., Koda M., Tanaka K., Fukuishi N., Gemba M. Stimulatory Effect of Cisplatin on Production of Lipid Peroxidation in Renal Tissues. Jpn J. Pharmacol. 1987; 43: 247–252
   PubMedGoogle Scholar
• Sugihara K., Nakano S., Gemba M. Effect of Cisplatin on In Vitro Production of Lipid Peroxides in Rat Kidney Cortex. Jpn J. Pharmacol. 1987; 44: 71–76
   PubMedGoogle Scholar
• Bogin E., Marom M., Levi Y. Changes in Serum, Liver and Kidneys of Cisplatin-Treated Rats: Effects of Antioxidants. Eur. J. Clin. Chem. Clin. Biochem. 1994; 32: 843–851
   PubMedGoogle Scholar
• Labriola D., Livingston R. Possible Interactions Between Dietary Antioxidants and Chemotherapy. Oncology 1999; 13: 1003–1008
   PubMed Web of Science ®Google Scholar
• Planting A.S., Catimel G., de Mulder P.H., de Graeff A., Hoppener F., Verweij J., Oster W., Vermorken J.B. Randomized Study of a Short Course of Weekly Cisplatin with or without Amifostine in Advanced Head and Neck Cancer. EORTC Head and Neck Cooperative Group. Ann. Oncol. 1999; 10: 693–700
   PubMed Web of Science ®Google Scholar
• Hensley M.L., Schuchter L.M., Lindley C., Meropol N.J., Cohen G.I., Broder G., Gradishar W.J., Green D.M., Langdon R.J., Jr., Mitchell R.B., Negrin R., Szatrowski T.P., Thigpen J.T., Von Hoff D., Wasserman T.H., Winer E.P., Pfister D.G. American Society of Clinical Oncology Clinical Practice Guidelines for the Use of Chemotherapy and Radiotherapy Protectants. J. Clin. Oncol. 1999; 17: 3333–3355
   PubMed Web of Science ®Google Scholar
• Hillman G.G., Forman J.D., Kucuk O., Yudelev M., Maughan R.L., Rubio J., Layer A., Tekyi-Mensah S., Abrams J., Sarkar F.H. Genistein Potentiates Radiation Effect on Prostate Carcinoma Cells. Clin. Cancer Res. 2001; 7: 382–390
   PubMed Web of Science ®Google Scholar
• DiPaola R.S., Zhang H., Lambert G.H., Meeker R., Licitra E., Rafi M.M., Zhu B.T., Spaulding H., Goodin S., Toledano M.B., Hait W.N., Gallo M.A. Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC–SPES) in Prostate Cancer. N. Engl. J. Med. 1998; 339: 785–791
   PubMed Web of Science ®Google Scholar
• Richardson M.A., Sanders T., Palmer J.L., Greisinger A., Singletary S.E. Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology. J. Clin. Oncol. 2000; 18: 2505–2514
   PubMed Web of Science ®Google Scholar
• Nam R.K., Fleshner N., Rakovitch E., Klotz L., Trachtenberg J., Choo R., Morton G., Danjoux C. Prevalence and Patterns of the Use of Complementary Therapies among Prostate Cancer Patients: an Epidemiological Analysis. J. Urol. 1999; 161: 1521–1524
   PubMed Web of Science ®Google Scholar
• Kucuk O., Sakr W., Sarkar F., Djuric Z., Wood D., Bertram J., Banerjee M. Lycopene Supplementation Decreases Serum PSA, PIN and Tumor Volume in Early Stage PCa. Proc. Am. Assoc. Cancer Res. 1999; 40: 409
   Google Scholar
• Davis J.N., Muqim N., Bhuiyan M., Kucuk O., Pienta K.J., Sarkar F.H. Inhibition of Prostate Specific Antigen Expression by Genistein in Prostate Cancer Cells. Int. J. Oncol. 2000; 16: 1091–1097
   PubMed Web of Science ®Google Scholar